Introducing Genetics in Medicine’s New Category – Therapeutics
Therapeutics Section Editor, Dwight D. Koeberl, MD, PhD of Duke University School of Medicine. Dr. Koeberl has a long-term research interest in the development of new therapies for rare disorders. He has initiated several clinical trials of new therapies for Pompe disease, including a Phase I clinical trial of liver depot gene therapy.
Call for Submissions
Submissions are now open for a new category of Therapeutics in Genetics in Medicine, the peer-reviewed journal of the American College of Medical Genetics and Genomics (ACMG)!
GIM is interested in Therapeutics submissions including, for example:
Early and late phase clinical trial results, natural history studies that inform future clinical trials, therapeutic biomarker validation, translational studies of gene therapy/editing, novel clinical study design for rare diseases, orphan drug development, and systematic reviews of genetic disease therapies. Manuscripts reporting only animal experiments typically will not be considered.
For more information on the journal and how to submit a manuscript, please visit Genetics in Medicine